As the U.S. Supreme Court kicks off its 2018 term this week, it
prepares to take up a series of firsts, including questions about
the America Invents Act, securities fraud and privacy-related class
action litigation. At the end of September, the Court also agreed
to resolve a long-running circuit split in a case involving Oracle
over how costs are awarded in copyright cases. The outcomes of
these and a number of other cases have potential business
implications for tech, life sciences and games companies. We've
prepared a list of the most important ones we think you should know
about.
In Helsinn Healthcare v. Teva Pharmaceuticals, the high
court will take its first stab at addressing whether amendments to
the America Invents Act narrow the scope of invalidating prior
sales to exclude "secret sales"—an important
question for companies in industries where product development
requires collaboration among several companies and years of work to
launch a product.
